“The SIA acquisition will deliver us One more phase nearer to reaching our ambition of turning out to be a world section chief and innovator in breast reconstruction with long term FDA approvals, financial investment in pipeline and evidence technology,” stated Jan De Witte, president and CEO, Integra LifeSciences.Having said that, for Edwards,